Nitra Hobbs Welch, ARNP

Nitra Welch practices at Blue Ocean Dermatology in Port Orange, Florida.

Nitra Welch's NPI, 1821141714, was assigned on January 22, 2007. Nitra Welch holds Florida license ARNP 3327692.

Nitra Welch's primary practice is Blue Ocean Dermatology, at 3951 S Nova Road, Port Orange, FL 32127. The practice phone is (386) 256-1444.

Nitra Welch's primary practice is Blue Ocean Dermatology in Port Orange, Florida. The medical group on file is Blue Ocean Dermatology. Dmand AI also links Nitra Welch to 1 more group practice or clinic, named with a free account. Nitra Welch's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Nitra Welch practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Nitra Welch's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Nitra Welch is licensed in Florida.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection, head wound and hives among the conditions Nitra Welch treats.

CMS data shows 2,797 Medicare services from Nitra Welch across 14 procedure codes in 2024, for 540 Medicare patients. Medicare paid $111,396 for them. Every service was in an office.

CMS counts 540 Medicare patients who saw Nitra Welch in 2024. The largest group is 65 to 74, with 274 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Nitra Welch's median patient age at 53, with 52% women.

In 2024, Nitra Welch wrote 533 Medicare Part D claims for 235 patients. 88% of them were for generic drugs. CMS names the drug for 354 of them, across 11 drugs with 11 or more claims each, at $94,730 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Nitra Welch for performance year 2024, reported individually. Nitra Welch accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 19 general payments to Nitra Welch from 7 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 89% of the total. Bristol-Myers Squibb Company paid the most, $188.